ReviewBiomedicines2024

Gemtuzumab Ozogamicin in Acute Myeloid Leukemia: Efficacy, Toxicity, and Resistance Mechanisms-A Systematic Review.

Aurelia Collados-Ros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.